Vaxart Inc. (VXRT) Stock’s Detailed Analysis

Vaxart Inc. (NASDAQ:VXRT) has a beta value of 0.74 and has seen 1.32 million shares traded in the last trading session. The company, currently valued at $532.30M, closed the last trade at $4.28 per share which meant it gained $0.07 on the day or 1.66% during that session. The VXRT stock price is -141.36% off its 52-week high price of $10.33 and 41.82% above the 52-week low of $2.49. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.18 million shares traded. The 3-month trading volume is 2.83 million shares.

The consensus among analysts is that Vaxart Inc. (VXRT) is an Overweight stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 4 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.19.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Sporting 1.66% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on Friday, 07/15/22 when the VXRT stock price touched $4.28 or saw a rise of 4.68%. Year-to-date, Vaxart Inc. shares have moved -31.74%, while the 5-day performance has seen it change -4.46%. Over the past 30 days, the shares of Vaxart Inc. (NASDAQ:VXRT) have changed 52.31%. Short interest in the company has seen 23.34 million shares shorted with days to cover at 10.42.

Wall Street analysts have a consensus price target for the stock at $9.75, which means that the shares’ value could jump 56.1% from current levels. The projected low price target is $6.00 while the price target rests at a high of $12.00. In that case, then, we find that the current price level is -180.37% off the targeted high while a plunge would see the stock gain -40.19% from current levels.

Vaxart Inc. (VXRT) estimates and forecasts

Figures show that Vaxart Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -26.84% over the past 6 months, with this year growth rate of -39.66%, compared to 11.10% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2022 fiscal year revenue. Growth estimates for the current quarter are -46.20% and -42.90% for the next quarter. Revenue growth from the last financial year stood is estimated to be 682.50%.

4 analysts offering their estimates for the company have set an average revenue estimate of $50k for the current quarter. 4 have an estimated revenue figure of $50k for the next quarter concluding in Sep 2022. Year-ago sales stood $112k and $270k respectively for this quarter and the next, and analysts expect sales will shrink by -55.40% for the current quarter and -81.50% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 41.40% over the past 5 years.

VXRT Dividends

Vaxart Inc. is expected to release its next earnings report between May 02 and May 06 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Vaxart Inc. (NASDAQ:VXRT)’s Major holders

Insiders own 0.83% of the company shares, while shares held by institutions stand at 36.27% with a share float percentage of 36.57%. Investors are also buoyed by the number of investors in a company, with Vaxart Inc. having a total of 208 institutions that hold shares in the company. The top two institutional holders are State Street Corporation with over 11.19 million shares worth more than $70.15 million. As of Dec 30, 2021, State Street Corporation held 8.85% of shares outstanding.

The other major institutional holder is State Street Corporation, with the holding of over 11.19 million shares as of Dec 30, 2021. The firm’s total holdings are worth over $70.15 million and represent 8.85% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund. As of Jan 30, 2022, the former fund manager holds about 7.85% shares in the company for having 9.92 million shares of worth $49.11 million while later fund manager owns 3.4 million shares of worth $21.31 million as of Dec 30, 2021, which makes it owner of about 2.69% of company’s outstanding stock.